推荐应用
C1q R1, also known as CD93 and C1q Rp, is an approximately 125 kDa transmembrane glycoprotein that is involved in various aspects of inflammatory reactions. Mature human CD93 consists of a 557 amino acid (aa) extracellular domain (ECD) with one C‑type lectin domain, four tandem EGF‑like domains, and a mucin‑like domain, followed by a 21 aa transmembrane segment and a 51 aa cytoplasmic domain. It is distinct from the 60 kDa Calreticulin which is likewise known as C1q R1. Unlike Calreticulin, and despite its name, C1q R1/CD93 does not appear to bind the complement protein C1q. CD93 is expressed by vascular endothelial cells and by a variety of hematopoietic cells. Various sized fragments of soluble CD93 (50‑75 kDa) can be shed from monocytes, neutrophils, and vascular endothelial cells following inflammatory stimulation, leaving a residual stub in the membrane. Cross‑linking of cell surface CD93 enhances phagocytosis by monocytes and enhances the uptake of apoptotic cells in vivo. Soluble CD93 promotes the differentiation of monocytes to macrophages, phagocytosis of apoptotic cells, and inflammatory responsiveness to multiple TLR ligands . It is required for plasma cell longevity in the bone marrow and for the resulting extended humoral response.
高纯度、高活性、低内毒素、高批间一致性
产品数据

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
89
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
79
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
107
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
88
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1811
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1798
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1087
2026-04-22
【应用方向】TNFR蛋白家族概述
1029
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1178
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
888
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
908
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
946
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
822
2026-04-20
【技术讲解】ADC药物研究相关靶点汇总
19371
2025-07-30
【应用方向】抗体药筛选的关键—靶点蛋白
11560
2025-07-09





